POINT Biomed Working on Series G


POINT Biomedical raised $4.3 million toward a Series G round of up to $25.7 million, according to a regulatory filing. POINT Biomedical disclosed the fund-raising in a Form D filed with the Securities and Exchange Commission last month. www.pointbio.com